Question follow-through · 25257
Gender Dysphoria: Puberty Suppressing Hormones
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the impact of the restriction of puberty blockers for the treatment of gender incongruence on the (a) physical and (b) mental health of young trans people.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 21 Jan 2025
- Target answer date
- 23 Jan 2025
- Answer
- 29 Jan 2025 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Prescription Drugs · 13 Feb 2025
- Prescription Drugs · 13 Feb 2025
- Epilepsy: Women · 13 Mar 2025
- Sodium Valproate: Compensation · 19 May 2025
- Cancer: Alcoholic Drinks · 4 Jun 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
21 Jan 2025
Question tabled
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the impact of the restriction of puberty blockers for the treatment of gender incongruence on the (a) physical and (b) mental health of young trans people.
23 Jan 2025
Target answer date
Date supplied by the official written-questions record.
29 Jan 2025
Answer published
On 11 December 2024 the Government introduced The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024, which came into effect on 1 January 2025. Alongside this legislation the Government published ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Prescription Drugs
13 Feb 2025 · To ask the Secretary of State for Health and Social Care, how many prescriptions were issued for each drug categorised under the (a) (i) clonazepam and (ii) other benzodiazepines, (b) z-drugs, (c) antidepressants, (d) opioids, (e) pregabalin and (f) gabap
Prescription Drugs
13 Feb 2025 · To ask the Secretary of State for Health and Social Care, with reference to the Answer of 27 January 2021 to Question 137239 on Prescription Drugs, what information his Department holds on the number of patients who have been prescribed drugs categorised
Epilepsy: Women
13 Mar 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking with Cabinet colleagues to support women with epilepsy.
Sodium Valproate: Compensation
19 May 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 May 2025 to Question 51501 on Sodium Valproate: Compensation, which Government departments he is having discussions with on developing a timetable for implementation of
Cancer: Alcoholic Drinks
4 Jun 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) recognise and (b) address the increased risk of developing cancer associated with alcohol consumption.
Cancer: Alcoholic Drinks
4 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether the National Cancer Plan will place a priority on (a) recognising and (b) addressing the cancer risks associated with alcohol.
Alcoholic Drinks: Labelling
4 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether his Department plans to consult on the potential merits of introducing mandatory standards for the labelling of alcohol products to include information on the risk of (a) drinking during pr
Alcoholic Drinks: Labelling
4 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential impact of introducing mandatory health labelling on alcoholic drinks on public health.
Cancer
4 Jun 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce the four out of 10 cases of cancer which are preventable.
Sodium Valproate: Compensation
16 Jun 2025 · To ask the Secretary of State for Health and Social Care, what discussions he has had with the Chancellor of the Exchequer on the potential merits of providing interim payments for people avoidably harmed by Sodium Valproate.
Sodium Valproate: Compensation
16 Jun 2025 · To ask the Secretary of State for Health and Social Care, what steps is he taking to ensure that people harmed by the drug Valproate in pregnancy will be fully compensated.
Sodium Valproate: Compensation
16 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether he has allocated funding for Valproate (a) financial redress and (b) interim payments.